Stock ENDV ENDONOVO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Endonovo Therapeutics, Inc.

Equities

ENDV

US29272H3003

Delayed OTC Markets
Other stock markets
 17:07:16 13/05/2024 BST 		5-day change 1st Jan Change
0.002 USD +33.33% Intraday chart for Endonovo Therapeutics, Inc. -9.09% -77.01%
2023 Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENDV Stock
  4. News Endonovo Therapeutics, Inc.
  5. MarketScreener Editorial Features